Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2361]

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers

Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA

Olaparib plus pembrolizumab shows promising results in BRCA mutated cancers ( Dr Timothy A. Yap - UT MD Anderson Cancer Center, Houston, USA )

Exploring colorectal cancer in Hispanic/Latino populations through multi-omics...

Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA

Exploring colorectal cancer in Hispanic/Latino populations through multi-omics analysis of MYC gene and WNT signalling pathway alteration ( Dr Enrique Velazquez Villarreal - CIty of Hope, Duarte, USA )

Metastasis-directed radiotherapy shows good prognosis for oligometastatic...

Dr Chad Tang - MD Anderson Cancer Center, Houston, USA

Metastasis-directed radiotherapy shows good prognosis for oligometastatic kidney cancer ( Dr Chad Tang - MD Anderson Cancer Center, Houston, USA )

Penpulimab in combination with chemotherapy for metastatic nasopharyngeal...

Dr Aditya Shreenivas - CIty of Hope, Duarte, USA

Penpulimab in combination with chemotherapy for metastatic nasopharyngeal cancer shows positive results ( Dr Aditya Shreenivas - CIty of Hope, Duarte, USA )

Addition of pembrolizumab to standard care shows promising results in advanced...

Dr Ravindra Uppaluri - Dana-Farber Brigham Cancer Center, Boston, USA

Addition of pembrolizumab to standard care shows promising results in advanced head and neck cancer ( Dr Ravindra Uppaluri - Dana-Farber Brigham Cancer Center, Boston, USA )

EGFR shows to be a promising therapeutic target in NF1 mutant melanoma

Dr Milad Ibrahim - NYU Langone Health, New York, USA

EGFR shows to be a promising therapeutic target in NF1 mutant melanoma ( Dr Milad Ibrahim - NYU Langone Health, New York, USA )

ELCC 2025: Latest in EGFR positive NSCLC

Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna...

ELCC 2025: Latest in EGFR positive NSCLC ( Dr Antonio Passaro, Prof Nicolas Girard, Prof Raffaele Califano and Dr Anna Minchom )

Understanding POEM syndrome: Diagnosis and treatment challenges

Dr Deonne Thaddeus Gauiran - University of the Philippines, Manila, Philippines

Understanding POEM syndrome: Diagnosis and treatment challenges ( Dr Deonne Thaddeus Gauiran - University of the Philippines, Manila, Philippines )

Advances in multiple myeloma treatment in the Philippines

Dr Flordeluna Z. Mesina, University of Santo Tomas Hospital - PCHTM, Manila...

Advances in multiple myeloma treatment in the Philippines ( Dr Flordeluna Z. Mesina, University of Santo Tomas Hospital - PCHTM, Manila, Philippines )

Adding durvalumab to neoadjuvant chemotherapy maintains quality of life in...

Dr Giulia Pasello - University of Padova, Padua, Italy

Adding durvalumab to neoadjuvant chemotherapy maintains quality of life in resectable NSCLC ( Dr Giulia Pasello - University of Padova, Padua, Italy )

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA...

Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany

Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC ( Prof Martin Reck - German Center of Lung Research, Grosshansdorf, Germany )

Taletrectinib superior to crizotinib in ROS1-positive non-small cell lung cancer

Dr Misako Nagasaka - UCI School of Medicine, Irvine, USA

Taletrectinib superior to crizotinib in ROS1-positive non-small cell lung cancer ( Dr Misako Nagasaka - UCI School of Medicine, Irvine, USA )

More from ecancer